QCI Asset Management’s Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock CDMOP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-80
Closed -$2K 516
2020
Q1
$2K Hold
80
﹤0.01% 534
2019
Q4
$2K Hold
80
﹤0.01% 557
2019
Q3
$2K Hold
80
﹤0.01% 548
2019
Q2
$2K Hold
80
﹤0.01% 584
2019
Q1
$2K Hold
80
﹤0.01% 569
2018
Q4
$2K Hold
80
﹤0.01% 575
2018
Q3
$2K Hold
80
﹤0.01% 562
2018
Q2
$2K Buy
+80
New +$2.02K ﹤0.01% 532

QCI Asset Management's CDMOP Position: Q2 2020 in Review

QCI Asset Management sold out of Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock (CDMOP) in Q2 2020, closing a stake of 80 shares — an estimated $2K sold.

QCI Asset Management first reported a position in CDMOP in Q2 2018 and held it in 8 quarters. The position peaked at $2K in Q1 2020. 0 funds tracked by Wall St. Rank hold CDMOP as of Q2 2020.

  • QCI Asset Management reported no remaining Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 80 Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock shares in Q2 2020, an estimated $2K.
  • QCI Asset Management first reported a position in Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock in Q2 2018 and held it in 8 quarters.
  • QCI Asset Management's Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock position peaked at $2K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.